Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
29 hedge funds and large institutions have $81.1M invested in Axcella Health Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 28 → 29 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
39% less capital invested
Capital invested by funds: $132M → $81.1M (-$50.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$885K |
| 2 |
AG
Artal Group
Luxembourg
|
+$446K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$387K |
| 4 |
CIC
Chilton Investment Company
Stamford,
Connecticut
|
+$333K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$1.59M |
| 2 |
Millennium Management
New York
|
-$146K |
| 3 |
Norges Bank
Oslo,
Norway
|
-$141K |
| 4 |
Neuberger Berman Group
New York
|
-$107K |
| 5 |
KC
KCL Capital
New York
|
-$93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
26
Ameritas Investment Partners
Lincoln,
Nebraska
| $1K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $1K | +$1.11K | +6 | +600% |
|
28
BNP Paribas Financial Markets
Paris,
France
| $458 | +$556 | +3 | New |
|
|
HM
29
HealthCor Management
New York
| – | -$1.59M | -6,826 | Closed |
|
|
KC
30
KCL Capital
New York
| – | -$93K | -400 | Closed |
|
31
Citigroup
New York
| – | -$2.78K | -15 | -83% |
|
AXLA Hedge Fund Activity: Q3 2019 in Review
29 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2019, worth a combined $81.1M — down 39% from $132M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AXLA positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Vanguard Group, adding an estimated $885K. The largest seller was HealthCor Management, exiting entirely with an estimated $1.59M sold.
- 29 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2019, up from 28 in Q2 2019.
- Funds reported $81.1M of Axcella Health Inc. Common Stock stock for Q3 2019, down 39% quarter-over-quarter.
- 3 funds opened new Axcella Health Inc. Common Stock positions in Q3 2019 and 2 closed out, a net change of +1 holder.
- The largest Axcella Health Inc. Common Stock buyer in Q3 2019 was Vanguard Group, an estimated $885K added.
- The largest Axcella Health Inc. Common Stock seller in Q3 2019 was HealthCor Management, an estimated $1.59M sold.
Based on aggregated 13F filings for Q3 2019.